New China Life Insurance Company Ltd. (SHA:601336)
China · Delayed Price · Currency is CNY 62.87
-0.27 (-0.43%)
Aug 3, 2026, 3:00 PM CST
SHA:601336 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 49,029 | 48,377 | 45,894 | 45,597 | 56,878 | 161,314 |
Total Interest & Dividend Income | -16,677 | -32,042 | -15,890 | 15,089 | 5,237 | 57,288 |
Gain (Loss) on Sale of Investments | 39,225 | 55,313 | 33,600 | -18,925 | 1,468 | -45 |
Other Revenue | 3,542 | 2,996 | 1,495 | 319 | 1,137 | 1,570 |
| 75,119 | 74,644 | 65,099 | 42,080 | 64,720 | 220,127 | |
Revenue Growth | 13.74% | 14.66% | 54.70% | -34.98% | -70.60% | 8.02% |
Policy Benefits | 29,619 | 30,243 | 29,992 | 31,571 | 33,083 | 173,464 |
Policy Acquisition & Underwriting Costs | - | - | - | - | - | 14,592 |
Selling, General & Administrative | 2,804 | 2,773 | 3,062 | 2,370 | - | 12,472 |
Other Operating Expenses | 797 | 749 | 712 | 620 | 3,861 | 3,042 |
Total Operating Expenses | 33,644 | 33,765 | 33,766 | 34,561 | 36,944 | 203,570 |
Operating Income | 41,475 | 40,879 | 31,333 | 7,519 | 27,776 | 16,557 |
Interest Expense | -3,355 | -3,510 | -3,166 | -2,086 | -1,173 | -800 |
Earnings From Equity Investments | - | - | - | - | -18 | - |
Currency Exchange Gain (Loss) | -255 | -162 | 80 | 113 | -4,506 | -116 |
Other Non Operating Income (Expenses) | 14 | -86 | -30 | -2 | - | - |
EBT Excluding Unusual Items | 37,879 | 37,121 | 28,217 | 5,544 | 22,079 | 15,641 |
Gain (Loss) on Sale of Assets | - | - | -3 | -1 | - | -5 |
Asset Writedown | - | - | - | - | - | -3 |
Other Unusual Items | 3,404 | 3,404 | -73 | -28 | - | 37 |
Pretax Income | 41,283 | 40,525 | 28,141 | 5,515 | 22,079 | 15,670 |
Income Tax Expense | 4,375 | 4,236 | 1,908 | -3,201 | 575 | 719 |
Earnings From Continuing Ops. | 36,908 | 36,289 | 26,233 | 8,716 | 21,504 | 14,951 |
Minority Interest in Earnings | -5 | -5 | -4 | -4 | -4 | -4 |
Net Income | 36,903 | 36,284 | 26,229 | 8,712 | 21,500 | 14,947 |
Net Income to Common | 36,903 | 36,284 | 26,229 | 8,712 | 21,500 | 14,947 |
Net Income Growth | 35.83% | 38.34% | 201.07% | -59.48% | 43.84% | 4.57% |
Shares Outstanding (Basic) | 3,123 | 3,120 | 3,120 | 3,120 | 3,120 | 3,120 |
Shares Outstanding (Diluted) | 3,123 | 3,120 | 3,120 | 3,120 | 3,120 | 3,120 |
Shares Change | 0.23% | - | - | - | - | - |
EPS (Basic) | 11.82 | 11.63 | 8.41 | 2.79 | 6.89 | 4.79 |
EPS (Diluted) | 11.82 | 11.63 | 8.41 | 2.79 | 6.89 | 4.79 |
EPS Growth | 35.51% | 38.34% | 201.32% | -59.51% | 43.84% | 4.58% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 112,096 | 109,434 | 95,190 | 89,458 | 86,727 | 70,595 |
Free Cash Flow Per Share | 35.89 | 35.08 | 30.51 | 28.67 | 27.80 | 22.63 |
Dividend Per Share | 2.730 | 2.730 | 2.530 | 0.850 | 1.080 | 1.440 |
Dividend Growth | 7.90% | 7.90% | 197.65% | -21.30% | -25.00% | 3.60% |
Operating Margin | 55.21% | 54.77% | 48.13% | 17.87% | 42.92% | 7.52% |
Profit Margin | 49.13% | 48.61% | 40.29% | 20.70% | 33.22% | 6.79% |
Free Cash Flow Margin | 149.22% | 146.61% | 146.22% | 212.59% | 134.00% | 32.07% |
EBITDA | 42,554 | 41,943 | 32,337 | 8,537 | 28,886 | 17,382 |
EBITDA Margin | 56.65% | 56.19% | 49.67% | 20.29% | 44.63% | 7.90% |
D&A For EBITDA | 1,079 | 1,064 | 1,004 | 1,018 | 1,110 | 825 |
EBIT | 41,475 | 40,879 | 31,333 | 7,519 | 27,776 | 16,557 |
EBIT Margin | 55.21% | 54.77% | 48.13% | 17.87% | 42.92% | 7.52% |
Effective Tax Rate | 10.60% | 10.45% | 6.78% | - | 2.60% | 4.59% |
Revenue as Reported | - | - | - | - | 108,164 | 222,380 |